DMBT1 anticorps

N° du produit ABIN7190483

L’anticorps Lapin Polyclonal anti-DMBT1 a été validé pour IHC et ELISA. Il convient pour détecter DMBT1 dans des échantillons de Humain.

Aperçu rapide pour DMBT1 anticorps (ABIN7190483)

Antigène: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DMBT1 est non-conjugé

Application: Immunohistochemistry (IHC), ELISA

Détail du produit anti-DMBT1 anticorps

Réactivité croisée: Humain, Souris, Rat

Purification: Antigen affinity purification

Immunogène: Synthetic peptide of Human DMBT1

Isotype: IgG

Information d'application

Indications d'application: ELISA:1:1000-1:2000, IHC:1:10-1:50,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur DMBT1

Antigène: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Autre désignation: DMBT1

Sujet:

Background: Loss of sequences from human chromosome 10q has been associated with the progression of human cancers. The gene DMBT1 was originally isolated based on its deletion in a medulloblastoma cell line. DMBT1 is expressed with transcripts of 6.0, 7.5, and 8.0 kb in fetal lung and with one transcript of 8.0 kb in adult lung, although the 7.5 kb transcript has not been characterized. The DMBT1 protein is a glycoprotein containing multiple scavenger receptor cysteine-rich (SRCR) domains separated by SRCR-interspersed domains (SID). Transcript variant 2 (8.0 kb) has been shown to bind surfactant protein D independently of carbohydrate recognition. This indicates that DMBT1 may not be a classical tumor suppressor gene, but rather play a role in the interaction of tumor cells and the immune system.

Aliases: Apactin antibody, CRP antibody, CRP-[a] antibody, CRP-[b] antibody, CRP-ductin antibody, Crpd antibody, DBMT1 antibody, Deleted in malignant brain tumors 1 antibody, Deleted in malignant brain tumors 1 protein antibody, DMBT 1 antibody, DMBT1 antibody, DMBT1 prototype precursor antibody, DMBT1/6kb.1 protein precursor antibody, DMBT1/8kb.1 protein antibody, DMBT1/8kb.2 protein precursor antibody, DMBT1_HUMAN antibody, Ebnerin antibody, FLJ61058 antibody, Glycoprotein 300 antibody, Glycoprotein 340 antibody, Gp 340 antibody, Gp-340 antibody, gp300 antibody, GP340 antibody, Gp340 variant protein antibody, Hensin antibody, MGC164738 antibody, Mucin-like glycoprotein antibody, Muclin antibody, OTTHUMP00000020654 antibody, OTTHUMP00000020655 antibody, OTTHUMP00000020656 antibody, OTTHUMP00000020657 antibody, OTTHUMP00000020658 antibody, OTTHUMP00000020659 antibody, OTTHUMP00000020660 antibody, OTTHUMP00000020661 antibody, OTTHUMP00000020662 antibody, OTTHUMP00000020663 antibody, p80 antibody, Pancrin antibody, SAG antibody, Salivary agglutinin antibody, Surfactant pulmonary associated D binding protein antibody, Surfactant pulmonary associated protein D binding protein antibody, Surfactant pulmonary-associated D-binding protein antibody, Vomeroglandin antibody

UniProt: Q9UGM3

Pathways: Activation of Innate immune Response